X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
On Wednesday, April 3, the Senate Finance Committee will hold its third hearing on drug-pricing this year, and five of the leading PBMs will be called to testify.

On April 3rd, pharmacy benefit managers (PBMs), the invisible middlemen of the health care industry, will be front and center for the world to see. No longer able to lurk behind the scenes, top executives from five PBMs—UnitedHealth Group’s Optum, Cigna Corp, Humana Inc, CVS Health Corp, CVS Caremark, and Prime Therapeutics LLC—have been invited to testify before Congress as part of a series of drug pricing hearings examining the healthcare marketplace and soaring drug costs.

BenefitsPRO Broker Expo 2020Event

The premier educational and networking event for employee benefits brokers and agents.

Get More Information
 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.